Llwytho...
miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1
The multidrug resistance (MDR) acquired in human osteosarcoma is a huge obstacle for effective chemotherapy. Recently, microRNA-26a (miR-26a) has been associated with the pathogenesis and progression of osteosarcoma. However, whether it regulates MDR in osteosarcoma is unknown. We show here that miR...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Front Cell Dev Biol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Frontiers Media S.A.
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8012539/ https://ncbi.nlm.nih.gov/pubmed/33816494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.645381 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|